Michael Garcia, MD, MS

PGY3

 

Educational Background

Radiation Oncology Residency, University of California San Francisco (2014-2018)

Preliminary Medicine Internship, Kaiser Permanente Santa Clara Medical Center (2013)

M.D., Harvard Medical School (2012)

M.S., Biological Sciences, Stanford University (2008)

B.S., Biological Sciences, Stanford University (2007)

Awards & Honors

Conquer Cancer Foundation of ASCO Merit Award (7/2016)

UCSF Patient Care Fund Award for prostate cancer patient education (5/2015)

Excellence in Medical Student Teaching, Kaiser Permanente (6/2013)

Harvard Linnane Scholar for academic excellence and community leadership (3/2010)

American Society of Hematology Minority Medical Student Award (3/2009)

National Collegiate Athletic Association (NCAA) Post-Graduate Scholar (6/2008)

Stanford Firestone Medal for top honors thesis (6/2007)

Stanford Center for Teaching & Learning Award for top thesis presentation (6/2007)

Stanford Chicano/Latino Community Senior Award (6/2007)

NCAA Division 1 National Champion (3/2007)

Three-time NCAA Division 1 All American in Track & Field (2004-2007)

Five-time NCAA Division 1 All Academic in Track & Field (2004-2007)

New Mexico House of Representatives Legislative Session Honor (2003)

Selected Publications

Garcia M, Lazar A, Duriseti S, Raleigh DR, Hess C, Fogh SE, Barani IJ, Nakamura JL, Larson D, Theodosopoulos P, McDermott M, Sneed PK, Braunstein S. Risks and outcomes for discovering additional brain metastases on day of stereotactic radiosurgery. Journal of Neurosurgery. 2016:1-8.

Raleigh DR, Solomon DA, Lloyd S, Lazar A, Garcia MA, Sneed PK, Clark JL, McDermott M, Berger M, Tihan T, Haas-Kogan DA. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro-Oncology. 2016; 0,1-22.

Garcia MA, Solomon D, Haas-Kogan DA. Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas. Future Oncology. 2016;12(12):1493-1506.

De Vita S, Schneider RK, Garcia M, Wood J, Gavillet M, Ebert BL, Gerbaulet A, Roers A, Levine RL, Mullally A, Williams DA. Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis. PLoS ONE 9(5): e96209. 2014

De Vita S, Mullaly A, Schneider-Kramann R, Garcia M, Ebert B, Gerbaulet A, Levine R, Williams D. Cooperation of KitD816V and TET2 Loss of Function in the Pathogenesis of Systemic Mastocytosis and Associated Hematological Malignancies. Experimental Hematology. 2013: 41(8): S15

Song JJ, Hwang I, Cho KH, Garcia MA, Kim AJ, Wang TH, Lindstrom TM, Lee AT, Nishimura T, Zhao L, Morser J, Nesheim M, Goodman SB, Lee DM, Bridges SL, Gregersen PK, Leung LL, Robinson WH. Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis. The Journal of Clinical Investigation. 2011 Sep; 121(9): 3517-3527.

Selected Abstracts

Garcia MA, Balboni TA, Braunstein S, Fogh SE, Anderson WG, Pantilat S, Taylor A, Spektor A, Krishnan M, Haas-Kogan, DA. Hertan L. Acute pain management in radiation oncology: Quality of care and the impact of an integrated palliative oncology service. Presented at the ASCO 2016 Palliative Care in Oncology Symposium. J Clin Oncol 34, 2016 (suppl 26S; abstr 32)

Garcia MA, Anderson W, Fogh S, Nakamura J, Theodosopoulos P, McDermott M, Sneed PK, Braunstein S. Poor prognostic indicators for patients treated with radiosurgery for brain metastases. Presented at the ASCO 2016 Palliative Care in Oncology Symposium. J Clin Oncol 34, 2016 (suppl 26S; abstr 195)

Garcia MA, Fogh SE, Anderson WG, Hertan L, Balboni T, Haas-Kogan DA, Braunstein S. Pain assessment at radiation oncology consultation for bone metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E514-E515. 2016 ASTRO Annual Meeting, Abstract # 3262

Yu Y, Garcia MA, Sneed PK, Braunstein S. Patterns of failure after adjuvant radiosurgery for surgically resected brain metastases: Surgical tract failures and implications for target delineation. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E130. 2016 ASTRO Annual Meeting, Abstract # 2316

Xu C, Garcia MA, Braunstein S. Influence of molecular subgroups and systemic therapy on outcomes of metastatic breast cancer patients receiving stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E134. 2016 ASTRO Annual Meeting, Abstract # 2327

Paulsson AK, Garcia MA, Fogh SE, Tingle C, Nakamura J, Sneed PK, Braunstein S. The impact of targeted therapy and immunotherapy on metastatic melanoma patients who undergo stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E134. 2016 ASTRO Annual Meeting, Abstract # 2264

Garcia MA, Anderson WG, Fogh SE, Barani IJ, Nakamura JL, Larson DA, Theodosopoulos P, McDermott M, Sneed PK, Braunstein S. Characteristics of patients with poor survival after Gamma Knife radiosurgery for brain metastases. 2016 Leksell Gamma Knife Society Meeting (May 15-19, 2016).

Garcia MA, Duriseti S. Fogh S, Barani IJ, Nakamura J, Larson D, Theodosopoulos P, McDermott M, Sneed PK, Braunstein S. Time between diagnostic MRI and frame-fixed stereotactic radiosurgery planning MRI is associated with brain metastasis growth but not worse local control.Neuro Oncol (2015) 17 (suppl 5): v196. 2015 Society of Neuro-Oncology Annual Meeting, Abstract #0813

Garcia M, Raleigh D, Magsoudi K, Braunstein E, Clarke J, Sneed PK, Fogh S, Larson D, Nakamura J, Barani IJ, Mueller S, Berger M, Haas-Kogan D. Outcomes and salvage therapy for recurrent choroid plexus tumors: A 25-year single institution experience. Int J Radiat Oncol Biol Phys. 2015;93(3):E504-E504. 2015 ASTRO Annual Meeting, Abstract #3260

Garcia MA, Maghsoudi K, Barani IJ, et al. Risks and Outcomes for Discovering Additional Brain Metastases on Frame-Fixed Stereotactic Radiosurgery Planning MRI Scan. Int J Radiat Oncol Biol Phys. 2015;93(3):E79-E79. 2015 ASTRO Annual Meeting, Abstract #2199.

Paulsson AK, Garcia MA, Wahl M, Raleigh, S.E. Fogh, D.A. Haas- Kogan, P.K. Sneed, and S.E. Braunstein . A Pilot Study of Educational Priming for Didactics in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015;93(3):E380-E380. 2015 ASTRO Annual Meeting, Abstract #2947.

Raleigh DR. Lloyd S, Solomon D, Lazar A, Tihan T, Sneed PK, Clarke J, Varenika V, Garcia MA, Mueller S, Berger M, and Haas-Kogan D. Outcomes and prognostic factors for pineal parenchymal tumors: A 25-year single institution experience. Int J Radiat Oncol Biol Phys. 2015;93(3):E63-E63. 2015 ASTRO Annual Meeting, Abstract #2157.

Berkova Z, Garcia MA,A Wang S, Wise J, Tao RH, Daniluk U, Samaniego F. Direct inhibition of Fas activation by CD74. 2009 American Society of Hematology Annual Meeting, Abstract # 3770

Song J, Nishimura T, Garcia MA, Myles T, Ho P, Du X, Sharif S, Leung L, Robinson W. Thrombin activatable carboxypeptidase B prevents anti-collagen antibody induced arthritis. Clinical Immunology 2007:123 suppl S98.

Selected Talks/Oral Presentations

Speaker. UCSF Radiation Oncology Update 2016. San Francisco, CA. Head and Neck Cancers Session; Head and Neck Cases. April 9th, 2016.

Speaker. UCSF Education Showcase 2016. San Francisco, CA. Palliative Care & Communication Skills curriculum for radiation oncology residents. April, 5th 2016.

Speaker. Society of Neuro-Oncology Annual Meeting. San Antonio, TX. Time between diagnostic MRI and frame-fixed stereotactic radiosurgery planning MRI is associated with brain metastasis growth but not worse local control. November 20, 2015.

Speaker. Grand Rounds Presentation. Cancer and the mind: The neurocognitive and neuropsychiatric effects of malignancy. Kaiser Permanente, Santa Clara, CA. May 6th, 2013

Speaker. American Society of Hematology Annual Meeting. New Orleans, LA. Talk Title: The role of CD74 in Blocking Apoptosis in Lymphoma.” December 7th, 2009.

Speaker. Stanford University Achauer Honors Symposium Platform Presentations for Top Honors Theses. Talk Title: Osteopontin is released from the mast cell by C5a stimulation and promotes mast cell migration. June 1st, 2007.